Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PACER T2: Order Sealing Motions 2-15-18 (filed 2-18-13)

Actually I think the problem over the past five years or so is that companies were not keen to license because of the continuous challenges to the validity of the patents themselves. Why would any company voluntarily license with the possibility of the patent being being thrown out altogether by the PTO?

They played chicken and they lost. Now pay up, big time.

Share
New Message
Please login to post a reply